We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PGC:NASDAQPeapack-Gladstone Financial Corporation Analysis

Data as of 2026-06-21 - not real-time

$44.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Peapack‑Gladstone (PGC) is trading at $44.75, comfortably above its 20‑day SMA of $44.13 and 50‑day SMA of $42.24, indicating a short‑term bullish bias, while the 200‑day SMA at $33.00 reinforces a longer‑term uptrend. The RSI sits at 56.5, suggesting momentum is still neutral to mildly bullish, but the MACD line is below its signal, generating a bearish histogram that could cap gains near the $46.57 resistance level. Volume is on an increasing trend, supporting the price advance, and the stock’s beta of 0.83 points to lower market‑wide volatility despite a 30‑day volatility reading of 25.7%. On the fundamentals side, revenue surged 25.5% YoY to $273.9 M, with an operating margin of 28% and a profit margin of 16%, while the balance sheet is strong—$264 M in cash versus $114 M of debt and a zero debt‑to‑equity ratio. The forward P/E of 9.38 and a DCF‑derived fair value of $116 imply a sizable upside, and the dividend yield of 0.45% with an 8% payout ratio underscores dividend sustainability. Overall, the stock blends technical strength with attractive valuation and solid fundamentals, making it a compelling candidate for investors seeking growth with modest income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages
  • Bearish MACD histogram near resistance
  • Increasing trading volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margin
  • Forward P/E of 9.38 indicating earnings expansion
  • Undervalued relative to DCF fair value and industry peers

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust balance sheet with ample cash and low leverage
  • Sustainable dividend with low payout ratio
  • Stable regional banking franchise with growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth25.50%
Profit Margin16.02%
P/E Ratio18.1
ROE6.64%
ROA0.59%
P/B Ratio1.2
Op. Cash Flow$75.6M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI56.5
Support$41.91
Resistance$46.57
MA 20$44.13
MA 50$42.24
MA 200$33.00
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$116.02
Target Price$48.44
Upside/Downside8.24%
GradeUndervalued
TypeGrowth
Dividend Yield0.45%

Risk Assessment

Beta0.83
Volatility25.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.